Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHA:603139)

SHA:603139 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,626	1,434	1,875	1,773	2,174	1,676
Market Cap Growth	96.11%	-23.49%	5.75%	-18.47%	29.74%	-2.56%
Enterprise Value	4,174	2,067	2,467	2,149	2,371	1,534
Last Close Price	36.30	14.36	18.77	17.75	21.69	16.65
PE Ratio	-	-	-	-	59.60	49.13
Forward PE	-	23.05	23.05	23.05	23.05	23.05
PS Ratio	7.06	2.55	2.79	3.61	4.91	4.05
PB Ratio	4.86	1.58	1.84	1.73	1.95	1.56
P/TBV Ratio	5.90	1.94	2.26	2.10	2.40	1.94
P/OCF Ratio	44.45	38.46	-	35.15	293.09	17.88
EV/Sales Ratio	8.13	3.68	3.67	4.37	5.36	3.70
EV/EBITDA Ratio	-	-	64.58	125.09	68.44	33.20
EV/EBIT Ratio	-	-	1797.74	-	129.78	44.79
Debt / Equity Ratio	0.90	0.70	0.66	0.53	0.44	0.07
Debt / EBITDA Ratio	-	-	17.18	31.66	14.30	1.67
Net Debt / Equity Ratio	0.79	0.59	0.50	0.31	0.15	-0.16
Net Debt / EBITDA Ratio	-6.98	-243.83	13.21	18.23	4.96	-3.75
Net Debt / FCF Ratio	12.46	-57.00	-3.49	-3.57	-0.61	1.01
Asset Turnover	0.26	0.28	0.35	0.27	0.28	0.34
Inventory Turnover	1.96	2.06	3.04	2.50	2.23	2.26
Quick Ratio	0.47	0.57	0.63	1.18	1.62	2.37
Current Ratio	0.79	1.00	1.00	1.61	2.09	2.94
Return on Equity (ROE)	-25.71%	-11.63%	-4.96%	-7.17%	3.02%	3.49%
Return on Assets (ROA)	-5.13%	-1.93%	0.04%	-0.28%	0.72%	1.75%
Return on Invested Capital (ROIC)	-11.60%	-4.11%	0.10%	-0.62%	1.43%	3.97%
Return on Capital Employed (ROCE)	-14.20%	-4.70%	0.10%	-0.60%	1.20%	3.00%
Earnings Yield	-5.07%	-6.25%	-1.40%	-3.56%	1.68%	2.04%
FCF Yield	1.30%	-0.65%	-7.71%	-4.95%	-13.01%	-10.25%
Dividend Yield	-	-	-	-	0.34%	0.42%
Payout Ratio	-	-	-	-	91.51%	29.25%
Buyback Yield / Dilution	0.60%	1.02%	-0.52%	-1.51%	1.73%	-0.89%
Total Shareholder Return	0.60%	1.02%	-0.52%	-1.51%	2.07%	-0.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.